Abstract
Ischemic stroke patients with thrombophilia and patient foramen ovale (PFO) may have an increased risk of recurrent stroke and transient ischemic attack (TIA), and may benefit from PFO closure. However, screening for thrombophilia is not routinely performed and the impact of thrombophilia on prognosis after PFO closure is uncertain. We aim to compare the risk of recurrent stroke and TIA after PFO closure in patients with thrombophilia versus those without. We performed a systematic review and meta-analyses of the literature, with a comprehensive literature search performed on 12 January 2023. Studies comparing the outcomes of patients with and without thrombophilia after PFO closure were included. The primary outcome evaluated was a recurrence of acute cerebrovascular event (ACE), a composite of recurrent ischemic stroke and recurrent TIA. The secondary outcomes included recurrent ischemic stroke only or TIA only. A total of 8 cohort studies were included, with a total of 3514 patients. There was an increased risk of stroke/TIA in patients with thrombophilia compared to those without thrombophilia after PFO (OR: 1.42, 95% CI: 1.01–1.99, I2 = 50%). The association between risk of TIA only (OR: 1.36, 95% CI: 0.77–2.41, I2 = 0%) and stroke only (OR: 1.09, 95% CI: 0.54–2.21, I2 = 0%) with thrombophilia did not reach statistical significance. There is an increased risk of recurrent cerebral ischemia event in patients with thrombophilia compared to those without thrombophilia after PFO closure. Future large prospective studies are necessary to characterise the risk and benefits of PFO closure, as well as the appropriate medical treatment to reduce the risk of recurrent stroke and TIA in this high-risk population.
Graphical Abstract
Similar content being viewed by others
Abbreviations
- CVD Risk Factors:
-
Cardiovascular Disease Risk Factors
- PFO:
-
Patent Foramen Ovale
- Total ACE:
-
Total Acute Cerebrovascular Events
- TIA:
-
Transient Ischaemic Attack
- DM:
-
Diabetes Mellitus
- HTN:
-
Hypertension
- HLD:
-
Hyperlipidaemia
- Smoking:
-
Current smokers only
- NA:
-
Not Applicable/ Available
References
Abrahamyan L, Schmidt S, Dharma AC, Everett C, Lee K, Canthiya DS, Kolker L, S., Horlick E (2023) Short- and long-term outcomes in patients with Thrombophilia Undergoing Transcatheter Closure of Patent Foramen Ovale. JACC: Cardiovasc Interventions 16(11):1360–1366. https://doi.org/10.1016/j.jcin.2023.04.027
Böhm G, Al-Khaffaf H (2003) Thrombophilia and arterial disease. An up-to-date review of the literature for the vascular surgeon. Int Angiol 22(2):116–124
Chiasakul T, De Jesus E, Tong J, Chen Y, Crowther M, Garcia D, Chai-Adisaksopha C, Messé SR, Cuker A (2019) Inherited Thrombophilia and the risk of arterial ischemic stroke: a systematic review and Meta‐analysis. J Am Heart Association 8(19). https://doi.org/10.1161/JAHA.119.012877
Elzanaty AM, Patel N, Sabbagh E, Eltahawy EA (2021) Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements. Curr Med Res Opin 37(3):377–384. https://doi.org/10.1080/03007995.2021.1876648
Farjat-Pasos JI, Nuche J, Mesnier J, Panagides V, Cloutier S, Houde C, Rodés-Cabau J (2022) Transcatheter patent Foramen Ovale Closure in Stroke patients with Thrombophilia: current status and future perspectives. J Stroke 24(3):335–344. https://doi.org/10.5853/jos.2022.01697
Girolami A, Simioni P, Scarano L, Girolami B (1997) Venous and arterial thrombophilia. Haematologica 82(1):96–100
Hviid CVB, Simonsen CZ, Hvas A-M (2019) Recurrence risk in patients with cryptogenic stroke, patent Foramen Ovale, and Thrombophilia: a systematic review and Meta-analysis. Thromb Haemost 119(11):1839–1848. https://doi.org/10.1055/s-0039-1693739
Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Saver JL, Smalling RW, Jüni P, Mattle HP, Meier B, Thaler DE (2016) Device Closure of Patent Foramen Ovale after Stroke. J Am Coll Cardiol 67(8):907–917. https://doi.org/10.1016/j.jacc.2015.12.023
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC, Turan TN, Williams LS (2021) 2021 Guideline for the Prevention of Stroke in patients with stroke and transient ischemic attack: a Guideline from the American Heart Association/American Stroke Association. Stroke 52(7). https://doi.org/10.1161/STR.0000000000000375
Lechat P, Mas JL, Lascault G, Loron PH, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y (1988) Prevalence of patent Foramen Ovale in patients with stroke. N Engl J Med 318(18):1148–1152. https://doi.org/10.1056/NEJM198805053181802
Liu K, Song B, Palacios IF, Inglessis-Azuaje I, Deng W, McMullin D, Wang X, Lo EH, Xu Y, Buonanno FS, Ning M (2020) Patent Foramen Ovale Attributable Cryptogenic Embolism with Thrombophilia has higher risk for recurrence and responds to Closure. JACC: Cardiovasc Interventions 13(23):2745–2752. https://doi.org/10.1016/j.jcin.2020.09.059
Martín F, Sánchez PL, Doherty E, Colon-Hernandez PJ, Delgado G, Inglessis I, Scott N, Hung J, King MEE, Buonanno F, Demirjian Z, de Moor M, Palacios IF (2002) Percutaneous Transcatheter Closure of Patent Foramen Ovale in patients with paradoxical embolism. Circulation 106(9):1121–1126. https://doi.org/10.1161/01.CIR.0000027819.19722.EE
Martorell L, Martínez-González J, Rodríguez C, Gentile M, Calvayrac O, Badimon L (2008) Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 99(02):305–315. https://doi.org/10.1160/TH07-08-0481
Mas J-L, Derex L, Guérin P, Guillon B, Habib G, Juliard J-M, Marijon E, Massardier E, Meneveau N, Vuillier F (2019) Transcatheter closure of patent foramen ovale to prevent stroke recurrence in patients with otherwise unexplained ischaemic stroke: Expert consensus of the French Neurovascular Society and the French Society of Cardiology. Arch Cardiovasc Dis 112(8–9):532–542. https://doi.org/10.1016/j.acvd.2019.06.002
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL (2019) Guidelines for the early management of patients with Acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of Acute ischemic stroke: a Guideline for Healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50(12). https://doi.org/10.1161/STR.0000000000000211
Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Buddy), Culebras A, Elkind MSV, George MG, Hamdan AD, Higashida RT, Hoh BL, Janis LS, Kase CS, Kleindorfer DO, Lee J-M, Moseley ME, Peterson ED, Turan TN, Valderrama AL, Vinters HV (2013) An updated definition of stroke for the 21st Century. Stroke 44(7):2064–2089. https://doi.org/10.1161/STR.0b013e318296aeca
Saver JL, Mattle HP, Thaler D (2018) Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic ischemic stroke. Stroke 49(6):1541–1548. https://doi.org/10.1161/STROKEAHA.117.018153
Turc G, Calvet D, Guérin P, Sroussi M, Chatellier G, Mas J (2018) Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke with Patent Foramen Ovale: systematic review of randomized trials, sequential Meta-analysis, and New insights from the CLOSE Study. J Am Heart Association 7(12). https://doi.org/10.1161/JAHA.117.008356
Webster MWI, Smith HJ, Sharpe DN, Chancellor AM, Swift DL, Bass NM, Glasgow GL (1988) PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS. Lancet 332(8601):11–12. https://doi.org/10.1016/S0140-6736(88)92944-3
Funding
No formal institutional funding or official sponsors were obtained.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
There were no competing conflicts of interests of review authors present.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lim, X.Y., Gao, N.L., Lee, W.Y. et al. Patent foramen ovale closure in ischemic stroke patients with and without thrombophilia: a systematic review and meta-analyses. J Thromb Thrombolysis (2024). https://doi.org/10.1007/s11239-024-02990-3
Accepted:
Published:
DOI: https://doi.org/10.1007/s11239-024-02990-3